MedTrace Logo

Feasibility Controlled Trial of Tibial Nerve Stimulation for Stroke Related Urinary Incontinence

NCT02239796 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2016-05-26

No results posted yet for this study

Summary

To aim of this study is to establish the feasibility of undertaking a phase III trial of transcutaneous posterior tibial nerve electrical stimulation (TPTNS) to alleviate stroke-related urinary incontinence.

Conditions

Interventions

DEVICE

NeuroTrac continence stimulators

Electrically stimulating the sacral nerve plexus modulates the L4-S3 nerve roots that control bladder function and urethral sphincter activity to eliminate inappropriate detrusor contractions while leaving the micturition reflex intact. Transcutaneous posterior tibial nerve stimulation (TPTNS) is a technique of non-invasive retrograde electrical stimulation of the sacral plexus via the sciatic nerve. The posterior tibial nerve, a tributary of the sciatic nerve, is accessed using surface electrodes applied to the medial malleolar area. We are using NeuroTrac continence stimulators.

DEVICE

NeuroTrac continence stimulators

We are using NeuroTrac continence stimulators.

Sponsors & Collaborators

  • The Stroke Association, United Kingdom

    collaborator OTHER

  • University of Central Lancashire

    collaborator OTHER

  • Nursing, Midwifery & Allied Health Professions Research Unit

    collaborator UNKNOWN

  • NHS Greater Glasgow and Clyde

    collaborator OTHER

  • NHS Lanarkshire

    collaborator OTHER_GOV

  • Glasgow Caledonian University

    lead OTHER

Principal Investigators

  • Joanne Booth · Glasgow Caledonian University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02239796 on ClinicalTrials.gov